Stay updated on Anti-IgE MAb in Allergic Asthma Clinical Trial
Sign up to get notified when there's something new on the Anti-IgE MAb in Allergic Asthma Clinical Trial page.

Latest updates to the Anti-IgE MAb in Allergic Asthma Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedDifference0.9%
- Check22 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed study information about CMAB007, a monoclonal antibody for asthma treatment, and the addition of new terms related to asthma and drug studies, such as 'Ventolin' and 'placebo'.SummaryDifference36%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check59 days agoChange DetectedDifference0.9%
Stay in the know with updates to Anti-IgE MAb in Allergic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-IgE MAb in Allergic Asthma Clinical Trial page.